MA29097B1 - Composes pour le traitement des infections virales par flaviviridae - Google Patents

Composes pour le traitement des infections virales par flaviviridae

Info

Publication number
MA29097B1
MA29097B1 MA29999A MA29999A MA29097B1 MA 29097 B1 MA29097 B1 MA 29097B1 MA 29999 A MA29999 A MA 29999A MA 29999 A MA29999 A MA 29999A MA 29097 B1 MA29097 B1 MA 29097B1
Authority
MA
Morocco
Prior art keywords
flaviviridae
compounds
treatment
viral infections
infections
Prior art date
Application number
MA29999A
Other languages
English (en)
Inventor
Beat Weidmann
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MA29097B1 publication Critical patent/MA29097B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA29999A 2004-12-23 2007-06-18 Composes pour le traitement des infections virales par flaviviridae MA29097B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63867604P 2004-12-23 2004-12-23

Publications (1)

Publication Number Publication Date
MA29097B1 true MA29097B1 (fr) 2007-12-03

Family

ID=36218613

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29999A MA29097B1 (fr) 2004-12-23 2007-06-18 Composes pour le traitement des infections virales par flaviviridae

Country Status (17)

Country Link
US (1) US20090214464A1 (fr)
EP (1) EP1830870A1 (fr)
JP (1) JP2008525458A (fr)
KR (1) KR20070089954A (fr)
CN (1) CN101084005A (fr)
AU (1) AU2005322241B2 (fr)
BR (1) BRPI0519355A2 (fr)
CA (1) CA2587586A1 (fr)
IL (1) IL183780A0 (fr)
MA (1) MA29097B1 (fr)
MX (1) MX2007007721A (fr)
NO (1) NO20073765L (fr)
NZ (1) NZ555142A (fr)
RU (1) RU2007128098A (fr)
TN (1) TNSN07240A1 (fr)
WO (1) WO2006071618A1 (fr)
ZA (1) ZA200703907B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2518265A1 (fr) 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Nouvelles cyclosporines
JP2008514702A (ja) 2004-09-29 2008-05-08 エーエムアール テクノロジー インコーポレイテッド 新規シクロスポリン類似体およびそれらの薬学的使用
US7378391B2 (en) 2004-09-29 2008-05-27 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
US7196161B2 (en) 2004-10-01 2007-03-27 Scynexis Inc. 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
WO2006041631A2 (fr) 2004-10-06 2006-04-20 Amr Technology, Inc. Alcynes de cyclosporine, et leur utilite comme agents pharmaceutiques
WO2007041631A1 (fr) 2005-09-30 2007-04-12 Scynexis, Inc. Derives d'arylalkyle et d'heteroarylalkyle de cyclosporine a utilises pour traiter et prevenir une infection virale
WO2007041632A2 (fr) 2005-09-30 2007-04-12 Scynexis, Inc. Procedes et compositions pharmaceutiques pour traiter et prevenir une infection par le virus de l'hepatite c
US7696165B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US7696166B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
CA2652662C (fr) 2006-05-19 2015-11-03 Scynexis, Inc. Procede de traitement et de prevention de troubles oculaires
WO2008069917A2 (fr) 2006-11-20 2008-06-12 Scynexis, Inc. Nouveaux peptides cycliques
JP5820722B2 (ja) 2008-06-06 2015-11-24 スシネキス インク シクロスポリン類似体及びhcv感染の治療におけるその使用
US8536114B2 (en) 2008-12-31 2013-09-17 Scynexis, Inc. Macrocycles
WO2011063076A1 (fr) 2009-11-19 2011-05-26 Itherx Pharmaceuticals, Inc. Méthodes de traitement du virus de l'hépatite c avec des composés d'oxo-acétamide
GB201116559D0 (en) 2011-09-26 2011-11-09 Univ Leuven Kath Novel viral replication inhibitors
PH12022551160A1 (en) 2019-11-15 2023-09-25 Janssen Pharmaceuticals Inc Treatment and prevention of dengue disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI111730B (fi) * 1990-11-02 2003-09-15 Novartis Ag Menetelmä ei-immunosuppressiivisen syklosporiinin valmistamiseksi
US5908621A (en) * 1995-11-02 1999-06-01 Schering Corporation Polyethylene glycol modified interferon therapy
FR2757521B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2757522B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
GB9811854D0 (en) * 1998-06-02 1998-07-29 Ciba Geigy Ag Organic compounds
CA2426381A1 (fr) * 2000-10-19 2002-04-25 Fujisawa Pharmaceutical Co., Ltd. Inhibiteur de degat cellulaire
GB0320638D0 (en) * 2003-09-03 2003-10-01 Novartis Ag Organic compounds
ATE490778T1 (de) * 2004-10-01 2010-12-15 Debiopharm Sa Verwendung von äd-mealaü3-äetvalü4-ciclosporin zur behandlung von hepatitis-c-infektion
WO2006071619A1 (fr) * 2004-12-23 2006-07-06 Novartis Ag Compositions pour le traitement du vhc

Also Published As

Publication number Publication date
AU2005322241B2 (en) 2010-02-18
JP2008525458A (ja) 2008-07-17
NO20073765L (no) 2007-09-19
MX2007007721A (es) 2007-08-14
KR20070089954A (ko) 2007-09-04
ZA200703907B (en) 2009-08-26
WO2006071618A1 (fr) 2006-07-06
US20090214464A1 (en) 2009-08-27
AU2005322241A1 (en) 2006-07-06
NZ555142A (en) 2010-03-26
CA2587586A1 (fr) 2006-07-06
CN101084005A (zh) 2007-12-05
IL183780A0 (en) 2007-09-20
EP1830870A1 (fr) 2007-09-12
TNSN07240A1 (en) 2008-11-21
RU2007128098A (ru) 2009-01-27
BRPI0519355A2 (pt) 2009-01-20

Similar Documents

Publication Publication Date Title
MA29098B1 (fr) Compositions pour le traitement du vhc
EP1951272A4 (fr) Utilisation de lactobacillus pour le traitement d'infections virales
EP1976516A4 (fr) Traitement de l'hépatite virale
EP2120565A4 (fr) Phosphoramidates cycliques nucléosidiques pour le traitement d'infections virales arn dépendantes
PL2987796T3 (pl) Fluorowco-podstawione boronoftalidy do leczenia zakażeń
DK1755661T3 (da) Gelsolin til anvendelse til behandling af infektioner
IL200116A0 (en) Compounds and pharmaceutical compositions for the treatment of viral infections
IL184955A0 (en) Tricyclic-nucleoside compounds for treating viral infections
LT2878297T (lt) Medikamentai, skirti fibrozinių ligų gydymui arba prevencijai
SI2193131T1 (sl) Imidazo(1,2-A)pirazin spojine za zdravljenje virusnih okuĹľb kot je hepatitis
EP1931691A4 (fr) Inhibiteurs d'odcase pour le traitement du paludisme
EP2621931A4 (fr) Dérivés d'indoles tétracycliques pour le traitement d'une infection par le virus de l'hépatite c
ATE541845T1 (de) 2,3-substituierte azaindolderivate zur behandlung von virusinfektionen
IL183032A0 (en) Andrographolide derivatives to treat viral infections
EP2621932A4 (fr) Composés hétérocycliques tétracycliques pour le traitement d'une infection par le virus de l'hépatite c
IL195272A0 (en) Methods and compositions for the treatment of viral infections
ATE533774T1 (de) Neuartige nukleosidanaloge zur behandlung von virusinfektionen
MA28394B1 (fr) Derives d'heteroaryle pour traitement des virus
EP1804787A4 (fr) Composition flavonoide pour le traitement des maladies bucco-dentaires
IL183780A0 (en) Compounds for flaviviridae treatment
FR2943537B1 (fr) Traitement des nevrites vestibulaires par l'acetyl-l-leucine
EP1626692A4 (fr) Composes permettant de traiter les infections par flavivirus
EP1789069A4 (fr) Peptides cycliques pour le traitement de cachexie
FR2876047B1 (fr) Traitement de polluants par phytolixiviation
DK2069353T3 (da) Polycykliske midler til behandling af infektioner med respiratorisk syncytialvirus